ESTRELLA IMMUNOPHARMA, INC. Prepaid Expense and Other Assets, Current
ESTRELLA IMMUNOPHARMA, INC. (ESLA) had Prepaid Expense and Other Assets, Current of $178.01 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $178.01K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $229.79K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $292.67K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $396.90K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $178.01K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $229.79K 10-Q · filed 2026-05-18 |
| 2025-12-31 | $292.67K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $396.90K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $163.93K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $522.79K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $723.86K 10-K · filed 2026-03-18 |
| 2024-09-30 | $437.64K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $288.76K 10-KT · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |